Medical and economic burden of heparin-induced thrombocytopenia: A retrospective nationwide inpatient sample (NIS) study

Ranjan Pathak, Vijaya R Bhatt, Paras Karmacharya, Madan Raj Aryal, Anthony A. Donato

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

In recent years, US hospitals have switched from use of unfractionated heparin to use of low-molecular-weight heparin, which is associated with lower risk of heparin-induced thrombocytopenia (HIT). In the study reported here, we retrospectively searched the Nationwide Inpatient Sample (NIS) for patients who were at least 18 years old and received a diagnosis of HIT between 2009 and 2011. Our goal was to get an updated perspective on the incidence and economic impact of HIT. We calculated the incidence of HIT overall and in subgroups of patients who underwent cardiac, vascular, or orthopedic surgery. We compared characteristics of patients with and without HIT and compared characteristics of patients with HIT with thrombosis (HITT) and HIT patients without thrombosis. Of 98,636,364 hospitalizations, 72,515 (0.07%) involved HIT. Arterial and venous thromboses were identified in 24,880 (34.3%) of HIT cases. Men were slightly more likely to have a HIT diagnosis (50.1%), but women had higher rates of HIT after cardiac surgery (odds ratio [OR], 1.41; 95% confidence interval [CI], 1.26-1.58) and vascular surgery (OR, 1.42; 95% CI, 1.29 - 1.57). Rates of HIT were 0.53% (95% CI, 0.51%-0.54%) after cardiac surgery, 0.28% (95% CI, 0.28%-0.29%) after vascular surgery, and 0.05% (95% CI, 0.05%-0.06%) after orthopedic surgery. HIT and HITT cases were significantly (P < 0.001) more likely than non-HIT cases to be fatal (9.63% and 12.28% vs 2.19%), and they had significantly higher costs and longer inpatient stays. HIT and especially HITT are associated with increased mortality, costs, and length of stay.

Original languageEnglish (US)
Pages (from-to)94-97
Number of pages4
JournalJournal of hospital medicine
Volume12
Issue number2
DOIs
StatePublished - Feb 2017

Fingerprint

Medical Economics
Thrombocytopenia
Heparin
Inpatients
Confidence Intervals
Thrombosis
Thoracic Surgery
Blood Vessels
Orthopedics
Odds Ratio
Costs and Cost Analysis
Low Molecular Weight Heparin
Incidence

ASJC Scopus subject areas

  • Leadership and Management
  • Internal Medicine
  • Fundamentals and skills
  • Health Policy
  • Care Planning
  • Assessment and Diagnosis

Cite this

Medical and economic burden of heparin-induced thrombocytopenia : A retrospective nationwide inpatient sample (NIS) study. / Pathak, Ranjan; Bhatt, Vijaya R; Karmacharya, Paras; Aryal, Madan Raj; Donato, Anthony A.

In: Journal of hospital medicine, Vol. 12, No. 2, 02.2017, p. 94-97.

Research output: Contribution to journalArticle

Pathak, Ranjan ; Bhatt, Vijaya R ; Karmacharya, Paras ; Aryal, Madan Raj ; Donato, Anthony A. / Medical and economic burden of heparin-induced thrombocytopenia : A retrospective nationwide inpatient sample (NIS) study. In: Journal of hospital medicine. 2017 ; Vol. 12, No. 2. pp. 94-97.
@article{25b40d3634d243439220f0bb2a8b499a,
title = "Medical and economic burden of heparin-induced thrombocytopenia: A retrospective nationwide inpatient sample (NIS) study",
abstract = "In recent years, US hospitals have switched from use of unfractionated heparin to use of low-molecular-weight heparin, which is associated with lower risk of heparin-induced thrombocytopenia (HIT). In the study reported here, we retrospectively searched the Nationwide Inpatient Sample (NIS) for patients who were at least 18 years old and received a diagnosis of HIT between 2009 and 2011. Our goal was to get an updated perspective on the incidence and economic impact of HIT. We calculated the incidence of HIT overall and in subgroups of patients who underwent cardiac, vascular, or orthopedic surgery. We compared characteristics of patients with and without HIT and compared characteristics of patients with HIT with thrombosis (HITT) and HIT patients without thrombosis. Of 98,636,364 hospitalizations, 72,515 (0.07{\%}) involved HIT. Arterial and venous thromboses were identified in 24,880 (34.3{\%}) of HIT cases. Men were slightly more likely to have a HIT diagnosis (50.1{\%}), but women had higher rates of HIT after cardiac surgery (odds ratio [OR], 1.41; 95{\%} confidence interval [CI], 1.26-1.58) and vascular surgery (OR, 1.42; 95{\%} CI, 1.29 - 1.57). Rates of HIT were 0.53{\%} (95{\%} CI, 0.51{\%}-0.54{\%}) after cardiac surgery, 0.28{\%} (95{\%} CI, 0.28{\%}-0.29{\%}) after vascular surgery, and 0.05{\%} (95{\%} CI, 0.05{\%}-0.06{\%}) after orthopedic surgery. HIT and HITT cases were significantly (P < 0.001) more likely than non-HIT cases to be fatal (9.63{\%} and 12.28{\%} vs 2.19{\%}), and they had significantly higher costs and longer inpatient stays. HIT and especially HITT are associated with increased mortality, costs, and length of stay.",
author = "Ranjan Pathak and Bhatt, {Vijaya R} and Paras Karmacharya and Aryal, {Madan Raj} and Donato, {Anthony A.}",
year = "2017",
month = "2",
doi = "10.12788/jhm.2687",
language = "English (US)",
volume = "12",
pages = "94--97",
journal = "Journal of hospital medicine (Online)",
issn = "1553-5606",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Medical and economic burden of heparin-induced thrombocytopenia

T2 - A retrospective nationwide inpatient sample (NIS) study

AU - Pathak, Ranjan

AU - Bhatt, Vijaya R

AU - Karmacharya, Paras

AU - Aryal, Madan Raj

AU - Donato, Anthony A.

PY - 2017/2

Y1 - 2017/2

N2 - In recent years, US hospitals have switched from use of unfractionated heparin to use of low-molecular-weight heparin, which is associated with lower risk of heparin-induced thrombocytopenia (HIT). In the study reported here, we retrospectively searched the Nationwide Inpatient Sample (NIS) for patients who were at least 18 years old and received a diagnosis of HIT between 2009 and 2011. Our goal was to get an updated perspective on the incidence and economic impact of HIT. We calculated the incidence of HIT overall and in subgroups of patients who underwent cardiac, vascular, or orthopedic surgery. We compared characteristics of patients with and without HIT and compared characteristics of patients with HIT with thrombosis (HITT) and HIT patients without thrombosis. Of 98,636,364 hospitalizations, 72,515 (0.07%) involved HIT. Arterial and venous thromboses were identified in 24,880 (34.3%) of HIT cases. Men were slightly more likely to have a HIT diagnosis (50.1%), but women had higher rates of HIT after cardiac surgery (odds ratio [OR], 1.41; 95% confidence interval [CI], 1.26-1.58) and vascular surgery (OR, 1.42; 95% CI, 1.29 - 1.57). Rates of HIT were 0.53% (95% CI, 0.51%-0.54%) after cardiac surgery, 0.28% (95% CI, 0.28%-0.29%) after vascular surgery, and 0.05% (95% CI, 0.05%-0.06%) after orthopedic surgery. HIT and HITT cases were significantly (P < 0.001) more likely than non-HIT cases to be fatal (9.63% and 12.28% vs 2.19%), and they had significantly higher costs and longer inpatient stays. HIT and especially HITT are associated with increased mortality, costs, and length of stay.

AB - In recent years, US hospitals have switched from use of unfractionated heparin to use of low-molecular-weight heparin, which is associated with lower risk of heparin-induced thrombocytopenia (HIT). In the study reported here, we retrospectively searched the Nationwide Inpatient Sample (NIS) for patients who were at least 18 years old and received a diagnosis of HIT between 2009 and 2011. Our goal was to get an updated perspective on the incidence and economic impact of HIT. We calculated the incidence of HIT overall and in subgroups of patients who underwent cardiac, vascular, or orthopedic surgery. We compared characteristics of patients with and without HIT and compared characteristics of patients with HIT with thrombosis (HITT) and HIT patients without thrombosis. Of 98,636,364 hospitalizations, 72,515 (0.07%) involved HIT. Arterial and venous thromboses were identified in 24,880 (34.3%) of HIT cases. Men were slightly more likely to have a HIT diagnosis (50.1%), but women had higher rates of HIT after cardiac surgery (odds ratio [OR], 1.41; 95% confidence interval [CI], 1.26-1.58) and vascular surgery (OR, 1.42; 95% CI, 1.29 - 1.57). Rates of HIT were 0.53% (95% CI, 0.51%-0.54%) after cardiac surgery, 0.28% (95% CI, 0.28%-0.29%) after vascular surgery, and 0.05% (95% CI, 0.05%-0.06%) after orthopedic surgery. HIT and HITT cases were significantly (P < 0.001) more likely than non-HIT cases to be fatal (9.63% and 12.28% vs 2.19%), and they had significantly higher costs and longer inpatient stays. HIT and especially HITT are associated with increased mortality, costs, and length of stay.

UR - http://www.scopus.com/inward/record.url?scp=85023608271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85023608271&partnerID=8YFLogxK

U2 - 10.12788/jhm.2687

DO - 10.12788/jhm.2687

M3 - Article

C2 - 28182804

AN - SCOPUS:85023608271

VL - 12

SP - 94

EP - 97

JO - Journal of hospital medicine (Online)

JF - Journal of hospital medicine (Online)

SN - 1553-5606

IS - 2

ER -